H3K9 acetylation in the Egr-1 binding sites (on-target region −98/+56 bp) and off-target region (−864/−793 bp) of GDNF promoter II was measured in high-grade and low-grade glioma tissues and normal brain tissue using ChIP-PCR. Here, GDNF is linked to central nervous system cancer.